PCVX — VAXCYTE INC

Ownership history in Edgestream Partners, L.P.  ·  4 quarters on record

This page tracks every 13F SEC filing in which Edgestream Partners, L.P. reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2023 Q4)
Avg. % of fund
0.04%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 30,771 -18,747 -37.9% 0.03% $1.1M $36.02
2025 Q2 ADDED 49,518 +45,932 +1280.9% 0.04% $1.6M $32.51
2024 Q4 REDUCED 3,586 -14,120 -79.7% 0.01% $294K $81.86
2023 Q4 INITIATED 17,706 — — 0.08% $1.1M —
% of Fund (quarterly)    PCVX price (monthly, adj. close)

Other funds also holding PCVX

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 24.48% Kynam Capital Management, LP 3Y 8.61% Saturn V Capital Management LP 3Y 6.77% Caligan Partners LP 3Y 6.48% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 5.07% Paradigm Biocapital Advisors LP 3Y 4.79% Elmind Capital, LP 3.97% Deep Track Capital, LP 3Y 3.29% Novo Holdings A/S 3Y 7Y 3.28% Eversept Partners, LP 3Y 7Y 2.78%
← Back to Edgestream Partners, L.P. Holdings